| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $21.1M | -1.5% |
| SG&A Expense | $14.2M | -7.8% |
| Operating Income | -$35.3M | +4.1% |
| Pre-tax Income | -$35.0M | +6.1% |
| Net Income | -$35.0M | +6.1% |
| EPS (Basic) | -$0.82 | +13.7% |
| EPS (Diluted) | -$0.82 | +13.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $50.6M | -25.3% |
| Current Assets | $54.8M | -31.7% |
| Total Assets | $55.5M | -31.6% |
| Current Liabilities | $9.2M | -7.4% |
| Total Liabilities | $9.3M | -9.4% |
| Stockholders' Equity | $46.2M | -34.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.0M | +31.2% |
| Capital Expenditures | $154K | +224.0% |
| Investing Cash Flow | -$154K | -224.0% |
| Financing Cash Flow | $6.0M | -85.7% |
| Free Cash Flow | -$23.2M | +30.8% |